/////

Agenda

ESMO

ESMO Virtual Data Briefing

14:30 - 15:30 CET
08:30 - 09:30 ET
Tuesday, September 22, 2020

 

SESSION TITLE

SPEAKERS

Opening and Welcome

Robert LaCaze, Member of the Executive Committee of Bayer’s Pharmaceutical Division and Head of the Oncology Strategic Business Unit

Bayer’s Commitment to Advancing Patient Care Through Research and Innovation

Dr. Scott Z. Fields, SVP and Head of Oncology Development at Bayer's Pharmaceuticals Division

Integrated Larotrectinib Analysis: Contextualizing Expanded Data for Patients with TRK Fusion Cancer

Professor Ray McDermott, MD, PhD, St. Vincent University Hospital and Tallaght Hospital, Ireland

Pediatric Focus: Understanding Larotrectinib for the Treatment of TRK Fusion Cancer in Children and Adolescents

Theodore W. Laetsch, MD, Children’s hospital of Philadelphia, Pennsylvania, USA

Interactive Media Q&A

All panelists